ECHA releases new chemical classification and labelling database

Published: 17-Mar-2014
Ingredients Regulatory

Aims to improve how ECHA makes this information available


The European Chemicals Agency (ECHA) has released a revised chemical database containing classification and labelling information on notified and registered chemical substances received from manufacturers and importers. Under the European Union’s (EU) REACH chemical control system, ECHA receives a comprehensive flow of information about chemicals.

The new database will improve how ECHA makes this information available for chemical-based companies such as pharmaceutical manufacturers. For instance, the database will include information about where a data supplier has indicated that an impurity or an additive is present. Researchers can differentiate between differently hydrated forms of the same substance. Publicly available IUPAC (International Union of Pure and Applied Chemistry) names for substances will be linked to chemicals as notified by data providers. And information on the effect of chemicals on organs, as well as other specific health effects and routes of exposure are also noted. 'ECHA aims to further enhance the user-friendliness and readability of the database,' said the Agency.

  • Companies:
  • ECHA European Chemicals Agency
See more

You may also like

Regulatory

EU biocidal product registry upgrade announced

Read more
R4BP 3.3 now has updated functionalities to help both industry and authorities make better use of their time, multitask, and meet their regulatory obligations

Trending Articles

  1. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  2. 2BScientific expands its life science product supply service to Europe with new German facility The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
  3. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  4. Merck's Welireg approved for cancers associated with von Hippel-Lindau disease in China The once-daily drug is the first HIF-2α to be approved in China, exhibiting a 49% objective response rate (ORR)
  5. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Regulatory

EU biocidal product registry upgrade announced

R4BP 3.3 now has updated functionalities to help both industry and authorities make better use of their time, multitask, and meet their regulatory obligations
Ingredients

ECHA proposes additional control on pharma purifier chemical

Because it can damage the environment
Regulatory

New EU regulation for export and import of hazardous chemicals comes into operation

ECHA takes over responsibility for the technical and administrative aspects of PIC
Ingredients

Pharma chemicals in new ECHA toxicity assessment list

Ethylene oxide is recommended for classification as potentially causing allergic skin reactions
Regulatory

ECHA opens up over biocides but users are unconvinced

Companies need to know which products they will keep in their portfolios, whether they can group products (for approval), and that the same approach will be taken at national and (European) Union level
Ingredients

ECHA increases REACH fees

SMEs will continue to pay less than larger companies
Ingredients

ECHA probes safety of cobalt salts used in pharma

EC will use findings to decide whether ECHA should draft use restrictions
Subscribe now